Leerink upgraded Spruce Biosciences (SPRB) to Outperform from Market Perform with a $160 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRB:
- Biotech Alert: Searches spiking for these stocks today
- Spruce Biosciences price target raised to $259 from $254 at Citizens JMP
- Spruce Biosciences Reports Q3 2025 Financial Results
- Spruce Biosciences reports Q3 EPS (14.58) vs. ($15.75) last year
- Spruce Biosciences files to sell 735K shares of common stock for holders